Risk prediction model for mortality in microscopic polyangiitis: multicentre REVEAL cohort study
Authors:
Open Access
- 20 November 2023
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 25 (1) , 1-9
Abstract
Background: To establish refined risk prediction models for mortality in patients with microscopic polyangiitis (MPA) by using comprehensive clinical characteristics. Methods: Data from the multicentre Japanese registry of patients with vasculitis (REVEAL cohort) were used in our analysis. In total, 194 patients with newly diagnosed MPA were included, and baseline demographic, clinical, laboratory, and treatment details were collected. Univariate and multivariate analyses were conducted to identify the significant risk factors predictive of mortality. Results: Over a median follow-up of 202.5 (84–352) weeks, 60 (30.9%) of 194 patients died. The causes of death included MPA-related vasculitis (18.3%), infection (50.0%), and others (31.7%). Deceased patients were older (median age 76.2 years) than survivors (72.3 years) (P < 0.0001). The death group had shorter observation periods (median 128.5 [35.3–248] weeks) than the survivor group (229 [112–392] weeks). Compared to survivors, the death group exhibited a higher smoking index, lower serum albumin levels, higher serum C-reactive protein levels, higher Birmingham Vasculitis Activity Score (BVAS), higher Five-Factor Score, and a more severe European Vasculitis Study Group (EUVAS) categorization system. Multivariate analysis revealed that higher BVAS and severe EUVAS independently predicted mortality. Kaplan–Meier survival curves demonstrated lower survival rates for BVAS ≥20 and severe EUVAS, and a risk prediction model (RPM) based on these stratified patients into low, moderate, and high-risk mortality groups. Conclusions: The developed RPM is promising to predict mortality in patients with MPA and provides clinicians with a valuable tool for risk assessment and informed clinical decision-making.Keywords
All Related Versions
This publication has 25 references indexed in Scilit:
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesArthritis & Rheumatism, 2012
- Estimation of BVAS in patients with microscopic polyangiitis in JapanClinical Rheumatology, 2011
- Overall survival, renal survival and relapse in patients with microscopic polyangiitis: a systematic review of current evidenceRheumatology, 2011
- A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitisArthritis Care & Research, 2011
- The Five-Factor Score RevisitedMedicine, 2011
- A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitisRheumatology, 2010
- Long-term follow-up of microscopic polyangiitis, 17-year experience at a single centerEuropean Journal of Internal Medicine, 2010
- EULAR recommendations for the management of primary small and medium vessel vasculitisAnnals of the Rheumatic Diseases, 2009
- EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitisAnnals of the Rheumatic Diseases, 2007
- Deaths Occurring During the First Year After Treatment Onset for Polyarteritis Nodosa, Microscopic Polyangiitis, and Churg-Strauss SyndromeMedicine, 2005